Feronia-XT

Quick links to important sections

Feronia-XT

Method of action: Antianemic

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Feronia-XT

Quick Facts

Property Description
Active Ingredients Ferrous Ascorbate, Folic Acid
Form Tablet, Suspension, Drops
Pharmacological Class Haematinic, Antianemic
Common General Use Addressing nutritional iron and folate deficiency
Origin Synthetic/Derived Combination Product

What Type of Medicine is Feronia-XT?

Feronia-XT is defined as a combination medicine categorized within the high-level therapeutic class of Haematinics and antianemics. These compounds are clinically recognized for their primary role in the prophylaxis and treatment of specific forms of anaemia. The product is an oral supplement available for Oral administration in several common dosage forms, including the Tablet, Suspension, and Drops, which allows for flexible use across various patient groups. This fixed-dose formulation is designed for combination supplementation in deficient populations.

Composition: Ferrous Ascorbate, Folic Acid, and Differentiation

The core active ingredients in Feronia-XT are Ferrous Ascorbate and Folic Acid. Ferrous Ascorbate is a specific chemical salt providing elemental iron combined with Ascorbic Acid (Vitamin C). This unique compound is recognized for its high bioavailability, meaning the body can absorb the iron it supplies. Folic Acid, or Vitamin B9, is included because folate deficiency frequently co-exists with iron deficiency. This strategic dual composition distinguishes the product from supplements that supply only a single nutrient.

What is the General Purpose of This Combination?

The general purpose of this specific formulation is to comprehensively address concurrent nutritional deficiencies of both iron and folate that lead to impaired blood cell production. By supplying the necessary elemental iron for haemoglobin structure and the Folic Acid required for rapid red blood cell (RBC) division (Erythropoiesis), the combination supports the formation and maturation of blood components. This combined action is utilized for maintaining blood health in situations like general Nutritional Anaemia.

Regulatory References

  1. NIH Fact Sheet for Health Professionals on Iron

What side effects are possible with Feronia-XT?

Possible side effects and safety information

The officially documented adverse reactions associated with oral iron and folic acid formulations are primarily centered on the Gastrointestinal System. These effects are generally classified as common and are often described as transient, with official regulatory notes indicating they may subside with the continuation of therapy.

Common Adverse Reactions and Expected Effects

Classification System-Organ Class Examples
Common Gastrointestinal System Nausea, vomiting, diarrhea, constipation, stomach upset, and heartburn (pyrosis).
Expected Gastrointestinal System The appearance of black stools or tarry stools is a noted, non-harmful consequence of unabsorbed iron.

Serious Safety Warnings and Restrictions

Acute Iron Overdose poses the most serious risk. Regulatory labeling explicitly warns that accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6 years of age. Severe acute overdose can rapidly progress to cardiovascular collapse and organ damage. The profile also addresses Hypersensitivity, classifying severe, systemic allergic reactions as rare.

Safety is also restricted by specific conditions. The medicine is contraindicated in patients with disorders of iron overload, such as hemochromatosis or hemosiderosis. Furthermore, the folic acid component requires caution: its use in patients with undiagnosed pernicious anemia may obscure the hematologic signs of Vitamin B12 deficiency while allowing associated neurological damage to progress.

Overdose and Emergency Response

Overdose and When to Seek Help

The officially documented overdose profile for Feronia-XT (Ferrous Ascorbate and Folic Acid) is primarily defined by the severe toxicity risk associated with the iron component.

Documented Overdose Manifestations

Overdose may initially present with severe gastrointestinal effects, including intense abdominal pain, persistent vomiting, and bloody diarrhea. Systemic signs of severe toxicity include low blood pressure (hypotension), a weak and rapid pulse, and pale skin, which can progress to hypovolemic shock. Severe cases are documented to affect the central nervous system, potentially causing convulsions (seizures), extreme lethargy, and coma. Later, serious outcomes such as metabolic acidosis and acute liver failure (hepatotoxicity) are recognized complications.

When to Seek Immediate Medical Attention

Accidental overdose of iron-containing products is officially recognized as a leading cause of fatal poisoning in children under 6. Due to this high risk, immediate action is mandatory. In case of suspected or accidental overdose, it is required to call a doctor or poison control center immediately. Individuals showing systemic signs, such as breathing difficulty or loss of consciousness, require immediate emergency medical attention. The folic acid component of the product has a low acute toxicity risk and is not associated with these life-threatening events.

Official Management Considerations

Hospital monitoring is generally required to assess the severity of toxicity, including the measurement of serum iron levels. Management involves symptomatic and supportive care. For severe toxicity, the specific chelating agent deferoxamine is documented in protocols for binding and eliminating excess iron.

Therapeutic Uses of Feronia-XT

What Feronia-XT Treats: Main Uses and Benefits

Feronia-XT is applied in addressing nutritional anaemia and associated symptoms by supplying the components needed to manage concurrent deficiencies of elemental iron and folic acid that can affect blood health. The core therapeutic domain is used to manage situations involving blood production where both nutrients are lacking. This approach supports the replenishment of these vital nutrients and helps manage the underlying deficiency.

This medication is relevant for easing symptom clusters such as persistent fatigue, generalized physical weakness, and diminished stamina in situations where patients experience symptoms related to systemic imbalance. The primary purpose is relevant for addressing the symptomatic manifestations of deficiency and assists with maintaining functional stability.

The medicine is commonly used during phases when symptoms become more noticeable due to increased physiological demand, particularly throughout pregnancy, lactation, and periods of rapid growth. This supportive use contributes to easing the overall symptom load by supplying necessary nutrients and plays a role in managing the risk of deficiency-related developmental issues.

Symptom Management

This combination is used for managing symptoms that interfere with daily functioning and is relevant for easing fatigue and weakness linked to systemic imbalance.

Regulatory References

  1. National Institutes of Health (NIH) Office of Dietary Supplements overview on Iron

Eligibility and Restrictions for Use

Eligibility Scope: Who Can and Cannot Use Feronia-XT?

Feronia-XT eligibility is strictly defined by regulatory documents based on patient comorbidities and specific life stages. Use is exclusively for individuals diagnosed with concurrent iron and folate deficiency anemia.

Eligibility Status Patient Condition
Contraindicated Conditions of Iron Overload (Hemosiderosis, Hemochromatosis) or Hemolytic Anemia
Contraindicated Anemias other than iron deficiency, including Pernicious Anemia or Vitamin B12 Deficiency
Contraindicated Active Gastrointestinal diseases like Peptic Ulcer or Ulcerative Colitis
Conditional Use History of peptic ulceration, post-gastrectomy, or underlying Kidney/Liver issues

Age and Physiological Status Rules

The Tablet formulation is generally not recommended for children or adolescents due to lack of established regulatory use. Use during pregnancy is conditional and often restricted to after the 13th week of pregnancy. Regarding lactation (breastfeeding), some official labels state Do not use, establishing a formal restriction for this period.


Official Eligibility Classifications

Regulatory documents define eligibility through strict classifications, including "Contraindicated" for absolute exclusion, "Conditional Use" for conditions requiring special caution, and "Not Recommended" for specific age groups with the tablet formulation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Feronia-XT interactions are primarily documented as pharmacokinetic in nature, involving the iron component's ability to chelate other substances, leading to reduced systemic exposure of co-administered medicines. The absorption of both Ferrous Ascorbate and Folic Acid is subject to interference from other agents.

Drug-Drug Interaction Constraints

Official regulatory documents classify co-administration with Deferiprone and Dimercaprol as restricted or prohibited due to risks of reduced efficacy or increased toxicity, respectively. The iron component significantly reduces the bioavailability of several drugs via chelation, including Tetracycline and Quinolone antibiotics, as well as the thyroid hormone Levothyroxine. Administration of these medicines requires a mandatory timing separation of at least two hours from Feronia-XT to mitigate absorption interference. Similarly, certain Anticonvulsants may have their efficacy reduced by the Folic Acid component, a documented pharmacodynamic interaction.

Food and Substance Interference

Iron absorption is officially inhibited by specific dietary substances, leading to a documented Drug-Food interaction. Consumption of milk, eggs, coffee, or tea concurrent with Feronia-XT significantly reduces the uptake of elemental iron. Antacids (containing carbonates or trisilicates) also inhibit iron absorption and require a two-hour separation period. Chronic use of Alcohol may decrease Folic Acid absorption and increase its elimination.

Population-Specific Caution

A specific regulatory caution exists for patients with undiagnosed anemia. Folic Acid supplementation, particularly in higher dosages, may mask the haematological signs of Vitamin B12 deficiency (Pernicious Anemia). While blood work may appear normalized, this interaction permits the progression of severe, irreversible neurological complications due to the underlying deficiency, an outcome noted in prescribing information.

Mechanism of Action

Feronia-XT acts by directly supplying and contributing to two core metabolic processes central to Erythropoiesis (red blood cell production).

Dual Precursor Delivery and Absorption

The ascorbate component increases the availability of Fe^2+ for absorption through the gastrointestinal tract, followed by transport to bone marrow cells via the Transferrin Receptor 1 (TFRC). Folic Acid is absorbed and metabolized to its active coenzyme form, Tetrahydrofolate (THF). This delivery system provides the essential biological building blocks necessary for red blood cell formation.

Coupled Synthesis of Hemoglobin and DNA

Once delivered, the components participate in interdependent synthetic pathways. The iron is incorporated into the Heme component, which is assembled into Hemoglobin (Hb). Simultaneously, THF acts as a crucial cofactor in one-carbon metabolism to synthesize the DNA and RNA building blocks required for rapid cellular division.

Modulation of Systemic Oxygen Transport

The mechanistic consequence of the preceding synthetic processes is the modulation of the blood's capacity for oxygen transport. By accelerating the production of new, mature red blood cells containing Fe^2+-rich hemoglobin, the mechanism directly influences the Hemoglobin concentration in circulation. This process contributes to the overall dynamics of Systemic Oxygen Transport and influences cellular oxygenation levels.

Dosage and Administration Information

Administration Scope

Feature Guideline
Route of Administration The medicine is administered orally for all available dosage forms (Tablet, Suspension, Drops).
Dosing Schedule Standard Adult Dose: One tablet (100 mg elemental iron/1.5 mg folic acid) once daily. Alternative Dose: May be increased to two tablets daily (200 mg elemental iron total).
Timing in Relation to Meals May be taken on an empty stomach for optimal absorption, or with meals to minimize gastrointestinal discomfort.
Preparation Requirements Must not be taken with tea, coffee, milk, or eggs, as these inhibit iron absorption.
Age-Group Administration Rules Pediatric Dose: Calculated as 3 to 6 mg elemental iron per kilogram of body weight daily, with a maximum daily limit of 180 mg elemental iron.
Missed-Dose Rules If a dose is missed, skip the missed dose and resume the regular schedule. Doubling the dose is prohibited.
Special Procedural Conditions Tablets must be swallowed whole. They are not to be crushed, broken, or chewed.

Connection to the Overall Use Protocol

The official administration guidelines establish a clear procedural structure focused on the oral route, defining the precise numerical dose ranges and the daily frequency for both adult and pediatric populations. This protocol explicitly details the required relationship between the dose and food/beverages to manage absorption alongside practical rules for tablet handling and the necessary action for a missed dose. Therapy is generally continued until the deficiency is corrected, with an additional period—often three months—for store replenishment.

Recent Clinical Evidence

Feronia-XT: Recent Clinical Evidence

Research into Ferrous Ascorbate and Folic Acid focuses on its use in nutritional anaemia and prophylaxis during pregnancy. The available evidence is derived primarily from Randomized Controlled Trials (RCTs), comparative studies, and systematic reviews.

Evidence for Addressing Nutritional Anaemia

RCTs and reviews have examined patients, including adults and children, with anaemia resulting from concurrent iron and folate deficiencies. Studies measured shifts in blood markers, such as Hemoglobin ( Hb) concentration and Serum Ferritin (iron stores), over short-term periods, typically ranging from four to twelve weeks.

Research findings describe patterns where these markers shifted toward correction in the observed populations. However, the evidence remains limited when directly comparing this specific iron salt to other common oral iron supplements. Some scientific reviews suggest that the measured difference in Hb may be clinically insignificant in certain comparisons.

Evidence for Prophylaxis during Pregnancy

The combination is studied for use in pregnancy primarily through meta-analyses that pool data from multiple trials. These studies explore outcomes related to the mother, such as the rate of maternal anaemia at delivery, and fetal outcomes, including low birth weight.

The synthesized research describes patterns where a lower prevalence of maternal anaemia at term was observed in populations who received supplementation. Despite this, certainty remains low for certain fetal outcomes, with the evidence quality for outcomes related to low birth weight often cited as very low.

What Remains Uncertain

Long-term effects are not fully established regarding the durability of the effect after supplementation ceases. Additionally, comparative evidence is lacking to definitively establish the difference in outcome of this specific iron salt over all other forms of oral iron. The research does not fully isolate the relationship between correcting blood markers and changes in patient-reported functional status, such as fatigue.

Frequently Asked Questions (FAQ)

Common questions about Feronia-XT (FAQ)


Q: What is the main difference between Feronia-XT and a regular iron supplement?

Official product information describes Feronia-XT as a combination medicine. It supplies both Ferrous Ascorbate (an elemental iron salt) and Folic Acid (Vitamin B9). This formulation is designed to address a combined deficiency of both nutrients, which distinguishes it from supplements containing only a single nutrient.


Q: How quickly can I expect to see a change after starting Feronia-XT?

Studies and official information indicate that changes in blood markers, such as Hemoglobin concentration, may begin to be measured in the weeks following the start of therapy. Because the body needs time for new blood cells to form, restoration of body stores is often a slow process, with replenishment typically assessed after about three months of therapy.


Q: Is Feronia-XT the same type of medicine as [similar competing drug name]?

Feronia-XT is formally classified by regulatory bodies as a Haematinic and an antianemic combination product. Medicines with the same official therapeutic classification and active ingredients fall into the same drug class, but each specific product has its own unique formulation and regulatory profile.


Q: What is the evidence behind Feronia-XT's reported benefits?

Available evidence, often derived from Randomized Controlled Trials, describes patterns where blood markers like Hemoglobin and Serum Ferritin shift toward correction in populations with nutrient deficiency. Research also describes patterns where a lower prevalence of maternal anaemia was observed in populations receiving supplementation during pregnancy.


Q: Is Feronia-XT safe to take with common pain relievers like ibuprofen?

Regulatory documents list specific interacting drugs, such as certain antibiotics and thyroid hormone medications, but do not specifically list ibuprofen as an interacting agent. Documented interactions primarily involve the iron component, which can interfere with the body’s uptake of other medicines.


Q: Can certain foods prevent Feronia-XT from working properly?

Yes, official labeling states that co-consumption with certain substances significantly reduces the body's uptake of the elemental iron. These documented inhibitors include milk, eggs, coffee, or tea. It is also noted that certain types of antacids can inhibit iron absorption.


Q: Is it possible to be allergic to Feronia-XT?

The product profile addresses the possibility of severe systemic allergic reactions, known as Hypersensitivity, classifying them as rare. Hypersensitivity to any component is noted as a condition that restricts use.


Q: Does Feronia-XT contain any common allergens like gluten or lactose?

Official drug labels list the active ingredients (Ferrous Ascorbate and Folic Acid). However, they typically do not provide a detailed breakdown of all inactive ingredients (excipients) to definitively confirm the exclusion of common allergens like gluten or lactose. This information is usually not explicitly detailed in the core regulatory summary.


Q: Is it okay to drink alcohol while taking Feronia-XT?

Regulatory documents indicate that chronic use of alcohol may be associated with decreased Folic Acid absorption and increased elimination of the nutrient. This potential interaction is a factor to consider in the context of long-term use.


Q: What should I know about taking Feronia-XT with thyroid medication?

Due to the potential for the iron component to reduce the absorption of thyroid hormones like Levothyroxine, regulatory information indicates that a timing separation between administrations is necessary to mitigate this interference. The specific instructions are detailed in the official prescribing information.


Q: Does Feronia-XT have a shelf life or expiration date I should know about?

Yes, regulatory storage guidelines refer to the disposal of 'unused or expired medicine,' which confirms that the product has a specific shelf life. This date is determined by the manufacturer to ensure the medicine's effectiveness and is typically printed on the product packaging.


Q: How long does the effect of one dose of Feronia-XT last in the body?

Pharmacokinetic data shows that the Folic Acid component is absorbed rapidly, with metabolic products largely cleared by the urine within about 24 hours. The iron component is absorbed more slowly, with its action supporting the body’s longer-term processes of blood cell production.


Q: Can Feronia-XT be used for purposes other than those listed on the label?

The medicine is formally authorized by regulatory bodies solely for the prophylaxis and treatment of specific forms of anaemia resulting from concurrent iron and folate deficiencies. Use is generally restricted to the official Indications and Usage that are established and monitored by health authorities.


Q: Is it normal to feel a bit dizzy when first taking Feronia-XT?

The officially documented common side effects are centered on the Gastrointestinal system (e.g., nausea, constipation). Dizziness is not listed as a common expected effect. However, it may be referenced in safety profiles in the context of more serious events.


Q: Is there a risk of becoming dependent on Feronia-XT?

Official regulatory documents do not classify this medicine as a controlled substance. Information regarding drug abuse and dependence does not describe a risk of physical or psychological dependence associated with the appropriate use of Feronia-XT.


Q: Will Feronia-XT interact with my daily multivitamin?

The iron component of the product can chelate with and potentially reduce the absorption of other minerals, such as calcium, which is often included in multivitamin formulas. The rate of iron absorption is also significantly influenced by the presence of other components, such as Vitamin C.


Q: Does caffeine or coffee interact with Feronia-XT?

Official labeling states that the absorption of the iron component is inhibited by the consumption of coffee concurrent with the medicine. This is a documented Drug-Food interaction that can reduce the overall uptake of elemental iron.


Q: Is Feronia-XT appropriate for older adults (seniors)?

Some regulatory labels note that the safety and effectiveness of this specific formulation may not have been established in elderly patients with the same level of detail as in other adult populations. Eligibility criteria are typically assessed based on the underlying health condition.


Q: Can Feronia-XT affect the results of other medical tests?

Official safety information indicates that the folic acid component may interfere with laboratory tests, specifically those used in the diagnosis of Pernicious Anemia. This interference occurs by obscuring the hematologic signs of an underlying Vitamin B12 deficiency.


Q: Is there any risk of iron overload with Feronia-XT?

Regulatory documents state that the medicine is contraindicated (prohibited) in patients with pre-existing iron overload disorders like Hemochromatosis. Furthermore, official labeling explicitly warns that Acute Iron Overdose poses a serious risk, especially as it is a leading cause of fatal poisoning in young children.


Q: What is the main chemical compound of the active ingredient in Feronia-XT?

The two core active ingredients are the specific iron salt compound, Ferrous Ascorbate, and the essential B-vitamin compound, Folic Acid (also known as Vitamin B9).


Q: Are there different forms of Feronia-XT (liquid, capsule, tablet)?

Official regulatory documents list the forms of the medicine available for oral administration. These include the Tablet, the Suspension, and the Drops.


Q: What happens if I stop taking Feronia-XT suddenly?

Regulatory information does not describe specific withdrawal effects upon cessation. Therapy is generally intended to continue until the deficiency is fully corrected and stores are replenished. Cessation before this duration is complete may mean the underlying nutrient deficiency is not fully addressed.


Q: Does Feronia-XT change or improve mood?

The mechanism of the medicine is focused on correcting the deficiency of iron and folate, which can be associated with symptoms like fatigue and general weakness. Official documents, however, do not contain established claims or data describing a direct effect on changing or improving mood.


Q: Can Feronia-XT be taken by people who are vegetarian or vegan?

The active ingredients are synthetic compounds (Ferrous Ascorbate and Folic Acid). While official labels list active ingredients, they do not consistently specify the animal origin of all inactive components (excipients) to definitively confirm suitability for vegetarian or vegan diets.


Q: What are the signs that Feronia-XT is actually working?

The medicine is considered to be working when follow-up laboratory studies show an increase in blood markers, such as Hemoglobin and Serum Ferritin. It is noted that patients with previously noticeable symptoms of deficiency may experience an improvement in issues such as fatigue or weakness.


Q: What is the difference between Feronia-XT and iron infusions?

Feronia-XT is a combination product designed for oral administration, meaning it is taken by mouth. In contrast, iron infusions are a medical procedure used for more severe deficiencies, involving the delivery of iron intravenously (directly into the vein).


Q: How does the body get rid of Feronia-XT once it's used?

Pharmacokinetic data shows that the Folic Acid component is metabolized in the liver, with metabolic products largely cleared by the urine within about 24 hours. Any unabsorbed iron component is naturally excreted through the feces.


Q: How does the way Feronia-XT is absorbed compare to other supplements?

Official documents note that the Ferrous Ascorbate component, which contains Vitamin C, is recognized for having high bioavailability. This means the specific iron salt is readily absorbed by the body through the gastrointestinal tract, especially when compared to some other forms of oral iron.


Q: If Feronia-XT helps with iron levels, why do some people not feel better immediately?

The therapeutic goal of the medicine is to rebuild the body's iron stores and generate new red blood cells, which is a gradual process. Because of this slow biological turnover, noticeable improvements in symptoms like fatigue may not occur immediately and could take several weeks, even as blood markers begin to shift.

How should Feronia-XT be stored and disposed of?

How to Store and Dispose of Feronia-XT?


Proper storage of Feronia-XT (Ferrous Ascorbate and Folic Acid) is crucial to maintain its effectiveness and safety. Keep the medicine in its original container, tightly closed, and out of reach of children and pets. Store it at room temperature, away from excess heat and moisture (not in the bathroom). Do not store it in places where it can freeze.

Disposal Guidelines

When disposing of unused or expired medicine, it is important to take measures to prevent harm to others. Do not flush Feronia-XT down the toilet or pour it into a drain unless instructed to do so by a healthcare provider or authorized medication take-back program. The best way to dispose of this medication is through a local medicine take-back program. If a take-back program is unavailable, consult a pharmacist or local waste disposal company for guidance on proper disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Feronia-XT found in:

A-Z Index: